- Infusion Pumps
- Metered Dose Inhalers
- Nebulizers
- Syringes
- Ocular Inserts
- Nasal Sprays
- Implantable Drug Delivery Devices
- Transdermal Patches
- Trans-Mucosal Drug Delivery Devices
- Others
Europe Drug Delivery Devices Market size was valued at USD x million in 2023 and is poised to grow at a significant CAGR of x% over 2024-2030. Drug delivery devices are used to deliver the drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevent various diseases such as diabetes, autoimmune disorders, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of drug by controlling dosage, time, and release the drug at specific site in the body.
Europe Drug Delivery Devices Market Dynamics
Drivers: Increase in the prevalence of chronic diseases such as diabetes and cancer due to change in lifestyle Rise in R&D activities for the innovation of newer devices Rise in demand for customized therapy and better availability of the products Restraints: Stringent regulation for the approval of drug delivery devices Product recalls and Complications in the use of drug delivery devices such as dosage errors High cost of drug delivery devices
Country Analysis
Europe Drug Delivery Devices Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Europe Drug Delivery Devices Market Segmentation
By Product Type
By Route Administration
- Oral
- Parenteral
- Transdermal
- Trans-Mucosal
- Inhalation
- Ocular
- Others
By Formulation Type
- Solid
- Liquid
- Semi-solid
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The Europe Drug Delivery Devices Market report covers are the Germany, France, Italy, Spain, and United Kingdom (UK)
The europe drug delivery devices market key players are Becton Dickinson and Company, Hoffmann La Roche Ltd., Smiths medical, Inc., Braun Melsungen AG, Pfizer, Inc., Merck & Co., Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, Eli Lilly and company, AptarGroup, Inc.
| 1.Executive Summary |
| 2.Europe Drug Delivery Devices Market Introduction |
| 2.1.Europe Drug Delivery Devices Market - Taxonomy |
| 2.2.Europe Drug Delivery Devices Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Route Administration |
| 2.2.3.Formulation Type |
| 2.2.4.Distribution Channel |
| 2.2.5.Country |
| 3.Europe Drug Delivery Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Europe Drug Delivery Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Europe Drug Delivery Devices Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Infusion Pumps |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Metered Dose Inhalers |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nebulizers |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Syringes |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Ocular Inserts |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Nasal Sprays |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Implantable Drug Delivery Devices |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Transdermal Patches |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Trans-Mucosal Drug Delivery Devices |
| 5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6.Europe Drug Delivery Devices Market By Route Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Transdermal |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Trans-Mucosal |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Inhalation |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Ocular |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Europe Drug Delivery Devices Market By Formulation Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Solid |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Liquid |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Semi-solid |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Europe Drug Delivery Devices Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Europe Drug Delivery Devices Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Germany |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. France |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Italy |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. United Kingdom (UK) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Spain |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.Germany Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Infusion Pumps |
| 10.1.2.Metered Dose Inhalers |
| 10.1.3.Nebulizers |
| 10.1.4.Syringes |
| 10.1.5.Ocular Inserts |
| 10.1.6.Nasal Sprays |
| 10.1.7.Implantable Drug Delivery Devices |
| 10.1.8.Transdermal Patches |
| 10.1.9.Trans-Mucosal Drug Delivery Devices |
| 10.1.10.Others |
| 10.2. Route Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.2.3.Transdermal |
| 10.2.4.Trans-Mucosal |
| 10.2.5.Inhalation |
| 10.2.6.Ocular |
| 10.2.7.Others |
| 10.3. Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Solid |
| 10.3.2.Liquid |
| 10.3.3.Semi-solid |
| 10.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital Pharmacies |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacies |
| 10.4.4.Others |
| 11.France Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Infusion Pumps |
| 11.1.2.Metered Dose Inhalers |
| 11.1.3.Nebulizers |
| 11.1.4.Syringes |
| 11.1.5.Ocular Inserts |
| 11.1.6.Nasal Sprays |
| 11.1.7.Implantable Drug Delivery Devices |
| 11.1.8.Transdermal Patches |
| 11.1.9.Trans-Mucosal Drug Delivery Devices |
| 11.1.10.Others |
| 11.2. Route Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.2.3.Transdermal |
| 11.2.4.Trans-Mucosal |
| 11.2.5.Inhalation |
| 11.2.6.Ocular |
| 11.2.7.Others |
| 11.3. Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Solid |
| 11.3.2.Liquid |
| 11.3.3.Semi-solid |
| 11.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital Pharmacies |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacies |
| 11.4.4.Others |
| 12.Italy Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Infusion Pumps |
| 12.1.2.Metered Dose Inhalers |
| 12.1.3.Nebulizers |
| 12.1.4.Syringes |
| 12.1.5.Ocular Inserts |
| 12.1.6.Nasal Sprays |
| 12.1.7.Implantable Drug Delivery Devices |
| 12.1.8.Transdermal Patches |
| 12.1.9.Trans-Mucosal Drug Delivery Devices |
| 12.1.10.Others |
| 12.2. Route Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.2.3.Transdermal |
| 12.2.4.Trans-Mucosal |
| 12.2.5.Inhalation |
| 12.2.6.Ocular |
| 12.2.7.Others |
| 12.3. Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Solid |
| 12.3.2.Liquid |
| 12.3.3.Semi-solid |
| 12.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital Pharmacies |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacies |
| 12.4.4.Others |
| 13.United Kingdom (UK) Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Infusion Pumps |
| 13.1.2.Metered Dose Inhalers |
| 13.1.3.Nebulizers |
| 13.1.4.Syringes |
| 13.1.5.Ocular Inserts |
| 13.1.6.Nasal Sprays |
| 13.1.7.Implantable Drug Delivery Devices |
| 13.1.8.Transdermal Patches |
| 13.1.9.Trans-Mucosal Drug Delivery Devices |
| 13.1.10.Others |
| 13.2. Route Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.2.3.Transdermal |
| 13.2.4.Trans-Mucosal |
| 13.2.5.Inhalation |
| 13.2.6.Ocular |
| 13.2.7.Others |
| 13.3. Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Solid |
| 13.3.2.Liquid |
| 13.3.3.Semi-solid |
| 13.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital Pharmacies |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacies |
| 13.4.4.Others |
| 14.Spain Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Infusion Pumps |
| 14.1.2.Metered Dose Inhalers |
| 14.1.3.Nebulizers |
| 14.1.4.Syringes |
| 14.1.5.Ocular Inserts |
| 14.1.6.Nasal Sprays |
| 14.1.7.Implantable Drug Delivery Devices |
| 14.1.8.Transdermal Patches |
| 14.1.9.Trans-Mucosal Drug Delivery Devices |
| 14.1.10.Others |
| 14.2. Route Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Oral |
| 14.2.2.Parenteral |
| 14.2.3.Transdermal |
| 14.2.4.Trans-Mucosal |
| 14.2.5.Inhalation |
| 14.2.6.Ocular |
| 14.2.7.Others |
| 14.3. Formulation Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Solid |
| 14.3.2.Liquid |
| 14.3.3.Semi-solid |
| 14.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospital Pharmacies |
| 14.4.2.Retail Pharmacies |
| 14.4.3.Online Pharmacies |
| 14.4.4.Others |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Becton Dickinson and Company |
| 15.2.2.Hoffmann La Roche Ltd. |
| 15.2.3.Smiths medical, Inc. |
| 15.2.4.Braun Melsungen AG |
| 15.2.5.Pfizer, Inc. |
| 15.2.6.Merck & Co., Inc. |
| 15.2.7.Sanofi S.A. |
| 15.2.8.Abbott Laboratories |
| 15.2.9.Novartis AG |
| 15.2.10.Eli Lilly and company |
| 15.2.11.AptarGroup, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Becton Dickinson and Company
- Hoffmann La Roche Ltd.
- Smiths medical, Inc.
- Braun Melsungen AG
- Pfizer, Inc.
- Merck & Co., Inc.
- Sanofi S.A.
- Abbott Laboratories
- Novartis AG
- Eli Lilly and company
- AptarGroup, Inc.